Sumatriptan Injection, Solution
Product Images NDC 70069-804

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 70069-804). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1 Label)

This is a prescription drug with the name Sumatriptan. It is available in the form of a single-dose vial containing 6mg of sumatriptan succinate in 0.5mL solution. The drug is meant for subcutaneous injection only and contains 3.5mg of sodium chioride. It is manufactured in India and distributed by Somerset Therapeutics LLC located in Hollywood, Florida, USA. The drug product should be stored at a temperature between 2°C to 30°C and light should be avoided. Please refer to the prescribing information for dosage information. The patient information leaflet should also be dispensed by the pharmacist.*

FDA Label Image

Carton5 (Carton5 Label)

This appears to be a label containing information about a medication called Sumatriptan Injection USP. It includes details such as the dosage (6mg/0.5mL), administration method (subcutaneous injection), and where it was manufactured (Somerset). It also mentions that certain details, such as lot number and expiration date, will be printed during the online packing process.*

FDA Label Image

Vial-label (Label Vial)

This is a medication packaging for Sumatriptan Injection used for subcutaneous injection with a dosage of 6mg/0.5mL manufactured by Somsract Thrapentice/LIS & USP in Hollywood, FL. The package contains a single-dose vial with a discard instruction for unused portions and a code "TN/Drugs/TN00003457". It is recommended to protect the medication from light, and the vial has an expiry date of "18x7mm".*

FDA Label Image

Sumatriptan-image01 (Sumatriptan Image01)

FDA Label Image

Image2 (Sumatriptan Image02)

This appears to be a chart showing the estimated percentage of patients experiencing relief, possibly from a medication or treatment. It includes information on a placebo group (N = 127) and a group taking Sumatriptan (N = 131) over a period of 25 minutes. However, without additional context or information, it is difficult to determine the specific context or implications of this data.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.